Could less treatment be just as good? study tests Spaced-Out dosing for blood cancer
Disease control
Not yet recruiting
This study is testing whether a maintenance therapy for multiple myeloma can be given less often while still working well. It will give the drug combination daratumumab-hyaluronidase every 8 weeks instead of every 4 weeks, along with the pill lenalidomide, to patients who have ha…
Phase: PHASE2 • Sponsor: Eden Biltibo • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC